FDA's Likely Approval to Relaunch Tysabri, Despite Rare Fatal Side ...
PharmaLive.com (press release) - Newtown,PA,USA
... and advisory firms focusing on pharmaceutical and health care issues, finds that the likely reintroduction of Biogen Idec/Elan's Tysabri (natalizumab) in the ...

Biogen and Elan's Tysabri gets positive EU opinion
Pharmaceutical Business Review - USA
... Medicinal Products for Human Use has issued a positive opinion recommending marketing authorization for Biogen Idec and Elan Corporation's Tysabri in relapsing ...